Cogentix Medical Makes $2 Million Investment in Israeli Company Developing Innovative and Novel Device for Delivery of Drugs to the Bladder. The agreement gives the Company the option to acquire all of Vensica at a fixed price if significant value creating milestones are achieved.
MISGAV, Israel, July 19, 2016 /PRNewswire/ -- Vensica Medical, a portfolio company of Trendlines Medical, announced the completion of... read more
The Official Networking and Conference App – Facilitating Partnering at the Innovation In Medtech Dublin 2016 event. This medical device... read more
Israeli startup Vensica is developing a needle-free, painless procedure for the delivery of Botox to treat overactive bladder. Israeli overactive... read more
© Copyright 2015. All Rights Reserved. 
Leave a Reply